191 – 200 of 650
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients : Results of the INSIGHT case-control study
(
- Contribution to journal › Article
-
Mark
At the Cross Section of Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome : A Narrative Review of Differential Diagnostics and a Problematization of Nomenclature
(
- Contribution to journal › Scientific review
-
Mark
Identification of Genetic Aberrations in Thrombomodulin Gene in Patients with Recurrent Venous Thromboembolism
(
- Contribution to journal › Article
-
Mark
Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism
(
- Contribution to journal › Article
-
Mark
If you know you will also see : Population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Plasma-derived versus recombinant factor concentrates in PUPs : A never ending debate?
(
- Contribution to journal › Article
-
Mark
Register-based studies to assess long-term outcome in haemophilia
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The impact of clinical practice on the outcome of central venous access devices in children with haemophilia
(
- Contribution to journal › Article
-
Mark
Outcome measures for adult and pediatric hemophilia patients with inhibitors
(
- Contribution to journal › Scientific review
-
Mark
Non-Vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin : A retrospective register study
(
- Contribution to journal › Article